Sartorius integrates online biomass measurement to its ambr systems for microbial applications

1 Apr 2019

Scientists to rapidly obtain detailed process understanding and control over their microbial cultures.

Sartorius Stedim Biotech (SSB) is introducing integrated online biomass measurement to its ambr 15 fermentation and ambr 250 high throughput systems for microbial applications.

Sartorius integrates online biomass measurement to its ambr systems for microbial applications

Already well known in the industry for fast-tracking microbial screening studies and shortening process development timelines, the ambr 15 fermentation and ambr 250 high throughput systems operate up to 24 single-use stirred bioreactor cultures in parallel. With the integration of online biomass measurement, SSB has addressed the bottleneck associated with offline sampling. The new online biomass capability features state-of-the-art non-invasive reflectance measurement, saving time, effort and sample volume. It enables scientists to rapidly obtain detailed process understanding and control over their microbial cultures.

Online biomass measurement provides real-time non-invasive, continuous growth monitoring of 24 microbial cultures running in parallel. The reflectance-based technology means that sampling is not required. Instead, it uses lasers to transmit light through the base of each bioreactor and microprocessors to translate this into a reflectance measurement. With a wide dynamic measurement range, and bubble correction factors to take into account gas bubble density, reliable online measurements can be achieved even in high aeration and agitation environments. Through a user calibration process, online reflectance can be displayed as online optical density (OD), wet cell weight (WCW) or dry cell weight (DCW). To date, the online biomass measurement has been successfully tested with different organisms including E.coli, Pichia pastoris, Saccharomyces cerevisiae, Streptomyces spp. and Corynebacterium spp.

“Fermentation scientists often have to perform time-consuming sampling to monitor growth and initiate process control based on offline data. Sample preparation and manual data handling can introduce variability and errors; it may also necessitate samples being taken at unsociable hours or over weekends,” explained Alison Rees-Manley, ambr 15 Product Manager at SSB. “By integrating innovative biomass monitoring technology into our ambr systems for microbial applications, we enable real-time growth data to be used for more advanced process control. We’re confident that these ambr systems will help scientists by reducing the burden of offline sampling and providing better process understanding and greater control of microbial cultures. This will result in more accurate and predictive data for cost-efficient protein production,” she added.

Read More

Related news

GSK partners with Samsung Biologics to secure additional manufacturing capacity

GSK partners with Samsung Biologics to secure additional manufacturing capacity

26 May 2020

The agreement will initially cover the commercial production of Benlysta (belimumab) with the intention to expand to additional specialty-care products in the future.

Read more 
Changes needed to prevent controversial pay-for-delay pharma deals

Changes needed to prevent controversial pay-for-delay pharma deals

26 May 2020

Researchers endorse a switch from the current first-filer system in the US to a system that instead rewards the first successful challenger.

Read more 
SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient

SeraNova and Carna Biosciences to develop oral formulation of a new active ingredient

26 May 2020

SeraNovo enters into a second license agreement with Carna Biosciences for development of oral formulation of Carna’s kinase inhibitor.

Read more 
AbCellera and Lilly seal multi-year antibody discovery collaboration

AbCellera and Lilly seal multi-year antibody discovery collaboration

25 May 2020

AbCellera, will use its antibody drug discovery platform to identify antibodies against up to nine targets.

Read more 
HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment

HKBU invents nanostructure that stimulates growth of stem cells for Parkinson's treatment

25 May 2020

The invention could pave the way for treatments to cure Parkinson's and Alzheimer's disease.

Read more 
Can the industry really claim it's 'business as usual'?

Can the industry really claim it's 'business as usual'?

19 May 2020

ChargePoint Technology's Chief Commercial Officer says "yes" it can.

Read more 
HKBU scientists develop technique to eliminate drug side effects

HKBU scientists develop technique to eliminate drug side effects

19 May 2020

The novel method paves the way towards the mass production of affordable therapeutic drugs that are made with recyclable materials.

Read more 
Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

Samsung Biologics expands business continuity excellence with additional ISO 22301 certification

19 May 2020

The certification is expected to instill greater 'supply' trust with clients, particularly during the current pandemic.

Read more 
Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

Vibalogics agrees to additional manufacturing for lead COVID-19 vaccine candidate of J&J unit

18 May 2020

CDMO is contracted to produce multiple clinical batches from German facility

Read more 
Pharmapack expert recommends holistic approach to sustainability

Pharmapack expert recommends holistic approach to sustainability

18 May 2020

Although the industry might be 30% along its sustainability journey, greater interoperability is needed from materials to devices.

Read more